• A Protein Therapeutics optimization company with a virtually-integrated drug discovery and development model

• Founded in 1999 by one of the pioneers in cytokine genetics and Human Genome Variability research, Dr Jean-Louis Escary

• Privately owned company

• Headquartered in Evry, France

• A strong focus on innovation with a keen eye on the balance sheet


GenOdyssee executive summary PDF

GO was founded in October 1999 by Dr. Jean-Louis Escary, Ph.D., Chairman and CEO, with the support from ANVAR, the French Agency for Innovation, and Génopôle 1er Jour, the Evry Génopôle incubator. Since its inception, the company has raised €17.0 million from French biotech venture funds, received €4.0 M in grants and generated €2.0 M in revenue .

Develop a new generation of biotherapeutics with higher therapeutic indices, based on an original approach of natural genetic variability.

GO is based in Les Ulis (corporate headquarters), France, 20 miles south of Paris and in Cambridge, Massachusetts (business development operations for the US).